Covid-19 and Down syndrome T21RS Survey, Report October 22, 2020

The Trisomy 21 Research Society has published a new research conducted by the T21RS to examine the risk of individuals with Down syndrome who have been diagnosed with COVID-19.

This work has been developed and undertaken by the T21RS COVID-19 taskforce, and supported by many stakeholder groups. The report contains information on symptoms, risk factors and outcomes following a COVID-19 diagnosis in people with Down syndrome.

The preprint report is open access and available here:

The T21RS has also developed a series of infographics highlighting key findings which has been updated: